... cells that predicted the benefit of a novel cancer drug prior to chemotherapy. Researchers looked at the effect ... expression levels (markers) predict efficacy of novel agents targeting tumor blood vessel ...
... genetic markers in cancer cells that predicted the benefit of a novel cancer drug prior to chemotherapy. Specific genetic profile within tumor cells may indicate increased patient benefit ...
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), ...
Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.
... of Missouri researchers have developed a new non-toxic treatment that effectively reduces breast cancer cells, by combining a small molecular drug that targets tumour cells with an antibody that ...
... network disrupted in several common cancers -- is a promising target for novel cancer therapies designed to shut it ... called PI(3)K that is an intense focus of cancer research and drug development. PI(3) ...
... signaling network disrupted in several common cancers — is a promising target for novel cancer therapies designed to shut it down. The report's lead authors are Shidong Jia, Zhenning Liu, ...
... major grant from the state of Florida to develop and commercialize a novel combination of agents that work to preferentially target and kill cancer cells, but not normal cells. The Florida Legislature ...
... power of sequencing entire genomes to discover novel cancer-related mutations," says senior author ... first complete DNA sequence of a human cancer genome, and its comparison to normal tissues of the same ...
... Sciences—now available online—may lead to a novel cancer therapy for humans.
"This research has far- ... should test the role of GRP78 in other types of cancer and isolate drugs that inhibit GRP78, Lee ...
... -RAS can cause a congenital illness as well as cancer . In this new study, Cristina Santoriello and colleagues ... control cancerous mutant H-RAS effects can potentially lead to novel cancer therapies ...
... that in the future these p21 inhibitors can be refined and used in concert with other conventional as well as novel cancer treatments to increase the comfort and life spans of patients with kidney ...
... with PPB are under five years old. The cancer progresses from air-filled lung cysts in ... that PPB lung tumors appear to result from a novel cancer induction mechanism not previously demonstrated. They ...
... United States each year. Close to two-thirds of these children are diagnosed after the cancer has metastasized to other parts of the body. For these patients with high-risk neuroblastoma, long-term ...
Researchers have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer.
